programs of South Korea and Taiwan cover more than 99% of the population due to the government's compulsory policy. However, NHIS data can be inaccurate. For instance, the num ber of patients with Kawasaki disease who did not receive intravenous immunoglobulin could be excluded from the NHIS data. 3) In the United States (US), the passive national sur veillance system reports to the Centers for Disease Control and Prevention, while an inpatient database of children and nation wide inpatient samples has been used for epidemiological surveys since the mid1970s. 7) The incidence rate of Kawasaki disease is much higher in Northeast Asia than in North America and Europe and continues to increase steadily. The latest incidence rates of Kawasaki disease were 308 in Japan (2014), 194.7 in South Korea (2014), 111.6 in Beijing (2014), 71.9 in Shanghai (2014), and 82.8 per 100,000 children aged below 5years in Taiwan (2010). 6) In North America, the incidence rates of Kawasaki disease were 19.6 in Canada (2014) and 19.1 per 100,000 children aged below 5 years in the US (2015). 6) Interestingly, outside Northeast Asian countries, the incidence of Kawasaki disease has not changed significantly since 1973, 5) but this might be because several cases go unreported or undiagnosed. In North America and Europe, most patients with Kawasaki disease are Asian. In Hawaii, the incidence rate of Kawasaki disease in Japanese Americans is as high as that reported in Japan. These data indicate that genetic susceptibility is closely related to the occurrence of Kawasaki disease. 5) The guideline for the diagnosis of Kawasaki disease has been revised since the first Japanese guideline was published in 1984. 8) The American Heart Association's guideline in 2017 newly recommends that Kawasaki disease can be diagnosed in the presence of a 4day fever together with at least 4 other principal clinical features of Kawasaki disease, although experienced clini cians who have treated many patients with Kawasaki disease be able to establish the diagnosis with a 3day fever in rare cases. 9) These recommendations can empower the specialist to treat patients with Kawasaki disease as soon as possible, thereby reducing coronary artery complica tions.
www.e-cep.org https://doi.org/ 10.3345/kjp.2019.00367 97 Two interesting findings from the epidemiological surveys on Kawasaki disease are seasonal peaks of incidence and geo graphical outbreak tendencies, which imply that some infectious agents may play roles in the pathogenesis of Kawasaki disease. It is postulated that some infectious agents may stimulate the immune system and induce Kawasaki disease in sus ceptible patients. 9) The meticulous surveillance of patients with Kawasaki disease by health care providers can enable the quick diagnosis and treatment of Kawasaki disease, thereby preventing coronary artery complications, such as giant aneurysms, and death. 6) The important factors for collecting exact epidemiological data are definite diagnosis, accurate number of patients with Kawasaki disease, and active participation of clinicians in epide miological surveys. Among the tools of nationwide surveys on Kawasaki disease, questionnaire data are more accurate than NHIS data. In conclusion, the com bination of nationwide epide miological surveys and use of NHIS data on Kawasaki disease will efficiently achieve an accurate epidemiological study of Kawasaki disease, which would help identify the etiology of Kawasaki disease.
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